mid-cap

2 US Listed Healthcare Stocks Under Watch Zone: Sema4 Holdings & T2 Biosystems

Aug 24, 2021 | Team Kalkine

Read Time :5 min

2 US Listed Healthcare Stocks Under Watch Zone: Sema4 Holdings & T2 Biosystems

Sema4 Holdings Corp

Sema4 Holdings Corp (NASDAQ: SMFR) was formerly known as CM Life Sciences Inc. It is a health intelligence company. SMFR focuses on advanced healthcare using data-driven insights.

Investment Highlights – Watch at USD 9.33

The Company made a loss from operations in Q2 FY2021.
Its cash declined from USD 1.09 million in FY2020 to USD 0.17 million in H1 FY2021.
On the liquidity front, SMFR’s current ratio in Q2 FY2021 has been much lower than 1.00x.
From a technical standpoint, the stock price is sustaining below the 20-day EMA of about USD 10.72. Hence, there could be a correction in the stock price in the near term.

One Year Share Price Chart

(Source: Refinitiv, Analysis done by Kalkine Group)

Conclusion

Based on its loss-making operations and reduced liquidity, we have given a "WATCH" stance on Sema4 Holdings Corp at the closing market price of USD 9.33 (as of 23 August 2021).

T2 Biosystems Inc

T2 Biosystems Inc (NASDAQ: TTOO) is a diagnostics company. It uses its T2MR technology and detects pathogens rapidly.

Investment Highlights – Watch at USD 0.91

The Company made a net loss in H1 FY2021.
TTOO is dependent on external funding to run its operation.
On the profitability front, TTOO’s gross margin in Q2 FY2021 has been much lower than the industry median of 85.4%.
On the liquidity front, TTOO’s current ratio in Q2 FY2021 has been lower than the industry median of 7.43x.
On the leverage front, TTOO’s debt/equity ratio in Q2 FY2021 has been much higher than the industry median of 0.00x.
From a technical standpoint, the stock price is sustaining below the 20-day EMA of about USD 1.00, indicating a potential correction in the stock price in the near term.

One Year Share Price Chart

(Source: Refinitiv, Analysis done by Kalkine Group)

Conclusion

Based on its loss-making operations and its dependence on external funding, we have given a "WATCH" stance on T2 Biosystems Inc at the closing market price of USD 0.91 (as of 23 August 2021).

*The reference data in this report has been partly sourced from Refinitiv.

Small-Cap

A Watch on Datadog: Building Competitive Advantage Through Platform Consolidation and AI Adoption

Jun 25, 2026 Team Kalkine

Small-Cap

How SNDG Works: The Mechanics of the Leverage Shares 2X Long SNDK Daily ETF

Jun 25, 2026 Team Kalkine

Blue-Chip

AI-Driven Memory Leadership and Strategic Customer Agreements Strengthen Long-Term Growth Outlook: MU

Jun 25, 2026 Team Kalkine

Small-Cap

Technical Analysis One NASDAQ - Listed IT Services Stock- XNDU

Jun 25, 2026 Team Kalkine

Small-Cap

GCT Semiconductor: Advancing 5G Innovation Through Commercial Expansion and Strategic Partnerships

Jun 25, 2026 Team Kalkine

Disclaimer-

Kalkine Equities LLC provides general information about companies and their securities. The information contained in the reports, including any recommendations regarding the value of or transactions in any securities, does not take into account any of your investment objectives, financial situation or needs. Kalkine Equities LLC is not registered as an investment adviser in the U.S. with either the federal or state government. Before you make a decision about whether to invest in any securities, you should take into account your own objectives, financial situation and needs and seek independent financial advice. All information in our reports represents our views as at the date of publication and may change without notice.

Kalkine Media LLC, an affiliate of Kalkine Equities LLC, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.

Past performance is not a reliable indicator of future performance.